Vesicular Stomatitis

Anitoa's turn-key swine flu test delivers breakthrough workflow simplicity and consistent, accurate results at the point-of-care SUNNYVALE, Calif., Dec. 4, 2023 /PRNewswire/ -- Anitoa Systems, LLC, a Silicon Valley biotechnology company and market leader in rapid, portable molecular testing, announced today worldwide availability of its all-in-one swine flu test solution for live stocks. Included in the test kit is an Anitoa's Maverick portable qPCR instrument, lyophilized swine flu test qPCR reagent, and a one-time-use sample collection tube with pre-filled lysis buffer solution. The complete turn-key test kit delivers breakthrough workflow simplicity and consistent, accurate results at the point-of-care for medium and small size farms with limited access to centralized lab tests. Anitoa's All-in-one swine flu test kit is expected to be available for sampling Q4'2023 and the company expects to ship the product in volume in 2024. Continue Reading Anitoa Systems, LLC Founded in 2013, with focus on point of care, on-site molecular tests on human, livestock and environment samples, Anitoa Systems made its first product debut by providing portable qPCR instruments to farms in Asia, mainly China, for testing farm animals. The All-in-one Swine Flu Test is part of an comprehensive menu of livestock and pet test kits offered by Anitoa. Other animal molecular tests offered by Anitoa include foot-and-mouth disease, tuberculosis, vesicular stomatitis and peste-des-petits-ruminants virus. The test kits combine sample collection, purification, and amplification detection in one package, which includes the instrument, reagent, and plastic consumables. The whole solution can easily fit into a backpack or medium suitcase. The product qualifies as a true a "lab-in-a-backpack" solution. Included in the all-in-one swine flu test kit is a 16-well Anitoa Maverick qPCR instrument with integrated Android touchpad interface. The instrument weighs less than 5 lb. and comes with a laptop style power adapter. A special adapter to draw power from car batteries or similar rechargeable batteries is also available from Anitoa systems. "Anitoa Systems was founded with deep commitment to support human, animal and environment tests with our portable, easy to use molecular testing solutions," said Dr. Zhimin Ding, CEO of Anitoa Systems, "as we believe human, animal and environmental health are connected." About Anitoa Anitoa Systems, a medical device technology start-up established in 2013 with headquarter in Sunnyvale, California, developed highly integrated and low-power CMOS-based bio-sensor devices for fluorescence and chemiluminescence sensing in portable molecular testing instruments. By replacing the traditional bulky and costly photon-multiplier tubes (PMT) and cooled CCDs, Anitoa's ultra-low-light CMOS sensor technology enables a new generation of compact and affordable molecular testing platforms targeting infectious pathogens in human, animals, our food and the environment. Anitoa manufactures its qPCR instruments and reagents in Hangzhou, China and Fremont, California, USA. For complete list of Anitoa's qPCR instrument and molecular test products please visit , or contact Anitoa Sales & PR at 408-887-6026. Media Contact: Sandra Liu 408-887-6026 [email protected] SOURCE Anitoa Systems, LLC

Material science and engineering and medical faculty members experimented with a material that has antiviral properties that are activated by white light, such as sunlight or LED lights. A team of UCF researchers have proven the efficacy of a nanomaterial-based disinfectant they developed to combat the spread of the COVID-19 virus. Through their experiments, they found that the disinfectant was able to kill several serious viruses including SARS and Zika. The results of their findings were recently published in ACS Applied Materials and Interfaces. "It is always a delight to have our research work featured in a reputed journal," said Udit Kumar, a doctoral student in the Department of Materials Science and Engineering (MSE) and the lead author of the journal article. "Given the theme and possible impact of antiviral research in current times, our article will definitely aid our fight against global pandemics." The paper outlines the most recent study from a multidisciplinary team of researchers that includes Sudipta Seal, the chair of the MSE department, and Griff Parks, a College of Medicine virologist and director of the Burnett School of Biomedical Sciences. They experimented with the nanomaterial yttrium silicate, which has antiviral properties that are activated by white light, such as sunlight or LED lights. As long as there is a continuous source of light, the antiviral properties regenerate, creating a self-cleaning surface disinfectant. "Yttrium silicate acts as a silent killer, with antiviral properties constantly recharged by the light," Kumar says. "It is most effective in minimizing surface to the surface spread of many viruses." Kumar says their test of yttrium silicate in white light disinfected surfaces with high viral loads in approximately 30 minutes. Additionally, the nanomaterial was able to combat the spread of other viruses including parainfluenza, vesicular stomatitis, rhinovirus, Zika and SARS. "This disinfectant technology is an important achievement for both engineering and health because we all were affected during the pandemic," Seal says. "COVID is still ongoing and who knows what other illnesses are on the horizon." Other UCF researchers, including College of Medicine postdoctoral researcher Candace Fox '16MS '19PhD, nanotechnology student Balaashwin Babu '20 and materials science and engineering student Erik Marcelo, are co-authors on the paper. "This publication is the culmination of timely insight by the investigators as to the importance of rapid development of broad-spectrum anti-microbials, as well as hard work in the lab to show the potency of our new materials," Parks says. "This is an outstanding example of the power of cross-discipline research -- in this case, materials science and microbiology researchers from CECS and COM." The research is funded by the U.S. National Science Foundation's RAPID program. Seal joined UCF's Department of Materials Science and Engineering and the Advanced Materials Processing Analysis Center, which is part of UCF's College of Engineering and Computer Science, in 1997. He has an appointment at the College of Medicine and is a member of UCF's prosthetics cluster Biionix. He is the former director of UCF's NanoScience Technology Center and Advanced Materials Processing Analysis Center. He received his doctorate in materials engineering with a minor in biochemistry from the University of Wisconsin and was a postdoctoral fellow at the Lawrence Berkeley National Laboratory at the University of California Berkeley. Parks is the College of Medicine's associate dean for Research. He came to UCF in 2014 as director of the Burnett School of Biomedical Sciences after 20 years at the Wake Forest School of Medicine, where he was professor and chairman of the Department of Microbiology and Immunology. He earned his doctorate in biochemistry at the University of Wisconsin and was an American Cancer Society Fellow at Northwestern University.